News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

J.S. Poceta, MD

Advertisement

Articles by J.S. Poceta, MD

Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262

ByDaniel F. Kripke, MD,Lawrence E. Kline, DO,Farhad F. Shadan, MD, PhD,Arthur Dawson, MD,J.S. Poceta, MD,Jeffrey A. Elliott, PhD
July 28th 2011

In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain.

Advertisement

Latest Updated Articles

  • Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262
    Melatonin Effects on Luteinizing Hormone in Postmenopausal Women: A Pilot Clinical Trial NCT00288262

    Published: July 28th 2011 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

FDA approves 5-year use for etonogestrel implant 68 mg contraceptive

2

Review finds no evidence linking prenatal paracetamol use to increased risk of autism, ADHD

3

Prenatal factors and offspring risk of adult multiple sclerosis

4

LPCN 1154 for postpartum depression continues clinical process after safety review

5

Breaking down biases against user-administered injectable contraceptives with Jennifer Karlin, MD

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us